PAMS
ZOM

Pictet Asset Management (Switzerland)’s Zomedica Corp. ZOM Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-51,237
Closed -$17K – 1731
2022
Q1 		$17K Hold
51,237
– – ﹤0.01% 1678
2021
Q4 		$16K Hold
51,237
– – ﹤0.01% 1717
2021
Q3 		$27K Buy
+51,237
New +$30.2K ﹤0.01% 1741

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s ZOM Position: Q2 2022 in Review

Pictet Asset Management (Switzerland) sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 51,237 shares — an estimated $17K sold.

Pictet Asset Management (Switzerland) first reported a position in ZOM in Q3 2021 and held it in 3 quarters. The position peaked at $27K in Q3 2021. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

  • Pictet Asset Management (Switzerland) reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 51,237 Zomedica Corp. shares in Q2 2022, an estimated $17K.
  • Pictet Asset Management (Switzerland) first reported a position in Zomedica Corp. in Q3 2021 and held it in 3 quarters.
  • Pictet Asset Management (Switzerland)'s Zomedica Corp. position peaked at $27K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 9 Aug 2022.